Get the Stockscreener App
21.04
1.01%
0.21
Nrc Health stock is traded at $21.04, with a volume of 45,683.
It is up +1.01% in the last 24 hours and up +1.64% over the past month.
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
See More
Previous Close:
$20.83
Open:
$20.92
24h Volume:
45,683
Relative Volume:
0.38
Market Cap:
$474.17M
Revenue:
$138.64M
Net Income/Loss:
$8.57M
P/E Ratio:
53.92
EPS:
0.3902
Net Cash Flow:
$17.43M
1W Performance:
-3.40%
1M Performance:
+1.64%
6M Performance:
-0.14%
1Y Performance:
+49.01%
1-Day Range:
$20.92
$21.55
1-Week Range:
$20.43
$22.11
52-Week Range:
$11.01
$23.00
Nrc Health Stock (NRC) Company Profile
Name
Nrc Health
Sector
Industry
Phone
(402) 475-2525
Address
1245 Q STREET, LINCOLN
Compare NRC vs VEEV, BTSG, HQY, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRC
Nrc Health
|
21.04 | 474.17M | 138.64M | 8.57M | 17.43M | 0.3902 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Nrc Health Stock (NRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-22-26 | Initiated | Citizens | Mkt Outperform |
Nrc Health Stock (NRC) Latest News
NRC Health (NRC) 16th Annual East Coast IDEAS Conference Summary - Quartr
NRC Health (NRC) Proxy filing Summary - Quartr
NRC Health (NRC) Q1 2026 earnings summary - Quartr
NRC Health (NRC) Investor presentation Summary - Quartr
NRC Health (NRC) Status update Summary - Quartr
NRC Q2'26 Earnings: revenue estimate is 34.90M USD - TradingView
Frontier tech research, news & data - MLQ.ai
Beebe Healthcare Launches New Survey Tool to Enhance Patient Experience - Beebe Healthcare
Charter and bylaw changes follow NRC Health (NRC) 2026 shareholder meeting - Stock Titan
Citizens reiterates NRC Health stock rating on sales momentum By Investing.com - Investing.com Nigeria
Citizens reiterates NRC Health stock rating on sales momentum - Investing.com
NRC Health(NasdaqGS: NRC) added to Russell 2000 Dynamic Index - marketscreener.com
Price to book forward of NRC Health – NASDAQ:NRC - TradingView
Price to book forward of NRC Health – FWB:NR1A - TradingView
Enterprise value to EBITDA forward of NRC Health – FWB:NR1A - TradingView
Enterprise value to revenue forward of NRC Health – FWB:NR1A - TradingView
Price to earnings forward of NRC Health – NASDAQ:NRC - TradingView
Price to sales forward of NRC Health – NASDAQ:NRC - TradingView
Enterprise value to EBIT forward of NRC Health – NASDAQ:NRC - TradingView
Form 4 NRC Health For: 25 June By Investing.com - Investing.com South Africa
NRC Health Actuals & Estimates (NASDAQ:NRC) - TradingView
Board member Donald Berwick receives $150,000 NRC (NRC) stock grant - Stock Titan
NRC Health (NRC) director awarded $150,000 in restricted stock units - Stock Titan
NRC Health (NRC) director awarded 7,697 restricted stock units - Stock Titan
Director John Nunnelly receives $150,000 NRC HEALTH (NRC) RSU grant - Stock Titan
NRC Health (NRC) grants director Penny Ann Wheeler 7,697 stock units - Stock Titan
NRC Forecast — Price Target — Prediction for 2027 - TradingView
Citizens reiterates NRC Health stock rating on growth outlook By Investing.com - Investing.com Australia
Citizens reiterates NRC Health stock rating on growth outlook - Investing.com
Tranche Update on NRC Health's Equity Buyback Plan announced on March 9, 2026. - marketscreener.com
NRC Health: Target Price Consensus and Analysts Recommendations | NRC | US6373722023 - marketscreener.com
NRC: All agenda items, including director elections and governance amendments, were approved - TradingView
NR1A Forecast — Price Target — Prediction for 2027 - TradingView
NRC Initiated Coverage by Citizens -- Price Target Set at $23.00 - GuruFocus
Citizens initiates NRC Health stock rating at outperform on dataset By Investing.com - Investing.com Australia
NRC Health initiated with an Outperform at Citizens - TipRanks
Citizens initiates NRC Health stock rating at outperform on dataset - Investing.com
Citizens JMP Initiates NRC Health(NRC.US) With Buy Rating, Announces Target Price $23 - Moomoo
How many employees work at NRC Health? - Revelio Labs
National Research Corp (NRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Have Insiders Sold NRC Health Shares Recently? - simplywall.st
Large NRC Health (NRC) holders detail 45.7% stake and recent stock sales - Stock Titan
NRC Health's Q1 earnings fall y/y due to elevated operating costs - MSN
NRC: Strong recurring revenue, AI-driven growth, and a major new client highlight future momentum - TradingView
NRC: Strong ARR growth, AI-driven products, and a major new client position the firm for continued expansion - TradingView
NRC Health partners with Healthcare Experience Foundation - Investing.com UK
NRC Health Partners with Healthcare Experience Foundation to Enh - GuruFocus
NRC Health and Healthcare Experience Foundation Form Partnership to Address Patient and Workforce Outcomes - geneonline.com
NRC Health and Healthcare Experience Foundation Launch Strategic - GuruFocus
NRC Health announces partnership with Healthcare Experience Foundation - TipRanks
NRC Health partners with Healthcare Experience Foundation By Investing.com - Investing.com South Africa
Nrc Health Stock (NRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nrc Health Stock (NRC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hays Michael D. | Chairman |
Jan 05 '26 |
Option Exercise |
15.23 |
9,145 |
139,278 |
20,154 |
| Hrdy Helen | EVP & Chief Operating Officer |
Dec 15 '25 |
Option Exercise |
15.23 |
12,346 |
188,030 |
151,762 |
| Freeman Jordan Nicole | Chief Accounting Officer |
Jul 31 '25 |
Buy |
12.97 |
771 |
10,000 |
771 |
1.99%
2.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):